BioSpace News Archive

Drug Development

Bluejay Therapeutics Presents Positive Preliminary BJT-778 Data from Phase 2 Clinical Trial in Chronic Hepatitis D at EASL 2024 Congress

Bluejay Therapeutics today announced positive preliminary data from the Phase 2 study of BJT-778, a fully human IgG1 monoclonal antibody that acts against hepatitis B surface antigen (anti-HBsAg mAb), in patients with chronic hepatitis D (CHD).

June 5, 2024
·
3 min read
Business

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.

June 5, 2024
·
4 min read
Genetown

EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

EyePoint Pharmaceuticals, Inc. today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 3:20 p.m. ET.

June 5, 2024
·
1 min read
Business

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

I-Mab enters clinical collaboration with Bristol Myers Squibb to evaluate Claudin 18.2 x 4-1BB bispecific antibody givastomig in combination with nivolumab and chemotherapy for the treatment of gastric and esophageal cancer.

June 5, 2024
·
6 min read
Genetown

Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference

Syndax Pharmaceuticals today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024.

June 5, 2024
·
1 min read
Business

Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer

Danaher Corporation today announced the creation of the new role of Chief Data & Artificial Intelligence Officer.

June 5, 2024
·
3 min read
Pharm Country

Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Passage Bio, Inc. today announced that William Chou, M.D., president and chief executive officer, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 4:00 p.m. ET.

June 5, 2024
·
1 min read
Deals

Telix Announces Launch of Proposed Initial Public Offering in the United States

Telix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial public offering in the United States (the “Offering”) of 17,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share in Telix.

June 5, 2024
·
6 min read
Clene to Present at the Emerging Growth Conference

Clene Inc. today announced that management will present at the Emerging Growth Conference.

June 5, 2024
·
2 min read
Drug Development

VYNE Therapeutics Announces Dosing of First Subject in Phase 2b Vitiligo Trial of Novel BET Inhibitor VYN201

VYNE Therapeutics Inc. today announced that the first subject has been dosed in a Phase 2b trial evaluating VYN201 in subjects with either active or stable nonsegmental vitiligo.

June 5, 2024
·
5 min read